Full Text View
Tabular View
No Study Results Posted
Related Studies
Open Label Study of Lithium Plus Extended-Release Carbamazepine (ERC-CBZ) for Rapid Cycling Bipolar Disorder
This study is ongoing, but not recruiting participants.
Study NCT00325286   Information provided by Creighton University
First Received: May 10, 2006   Last Updated: December 13, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bipolar Disorder
Additional conditions recognized in this trial
Disease
More general conditions related to this trial
Affective Disorders, Psychotic
Mental Disorders
Mood Disorders
Pathologic Processes
Additional drug interventions recognized in this trial
Carbamazepine
Lithium
Lithium Carbonate
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Anticonvulsants
Antidepressive Agents
Antimanic Agents
Antipsychotic Agents
Central Nervous System Agents
Central Nervous System Depressants
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Sensory System Agents
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Creighton University
Shire Pharmaceutical Development


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services